BioNTech SE - ADR vs Kinder Morgan Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Kinder Morgan Inc trades at $31.59 (market cap $70.10B). The key difference: Kinder Morgan Inc is far larger — about 3× BioNTech SE - ADR's market cap, and Kinder Morgan Inc pays a 3.75% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | KMI | |
|---|---|---|
Market Cap | $23.31B | $70.10B |
Sector | Health | Energy |
52-Week High | $119.34 | $34.31 |
52-Week Low | $83.89 | $25.84 |
Enterprise Value | $6.60B | $102.15B |
Dividend Yield | — | 3.75% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Kinder Morgan is one of the largest midstream energy firms in North America, with an interest in or an operator on about 83,000 miles in pipelines and over 140 storage terminals. The company is active in the transportation, storage, and processing of natural gas, crude oil, refined products, natural gas liquids, and carbon dioxide. The majority of Kinder Morgan's cash flows stem from fee-based contracts for handling, moving, and storing fossil fuel products.
Read more on KMI →